The EU’s medicines regulator said Wednesday it had been the victim of a cyberattack
The institution responsible for supervising the development and marketing of new drugs, including vaccines against Covid-19, announces that it is opening an investigation.
A computer attack targeted the European Medicines Agency on Wednesday, according to a short press release from the institution responsible for validating new drugs in the European Union.
The organization founded in 1995, headquartered in Amsterdam (Netherlands), states that it cannot communicate more details on the subject for the time being, in particular, because of the ongoing investigation. It is therefore impossible to know the extent of this cyberattack, nor the nature of the infrastructures concerned.
The European Medicines Agency is particularly active in the fight against Covid-19. It must in particular rule on the marketing authorization of the first two vaccines against the coronavirus before December 29, announced Jean Castex at the beginning of the month. A step which will precede the potential authorization of the High Authority of Health, so that a vaccination campaign can begin in the Hexagon.
The two vaccines concerned are that of the company Moderna and that developed by Pfizer. It is the latter which was administered on December 8 to Margaret Keenan, 90, the very first patient (excluding trials) to be vaccinated in the United Kingdom.